Security
QT IMAGING HLDGS INC Warrant · QTIWW
QTIWWOTCWarrantCurrentCIK 1844505Updated Oct 6, 2026
QTIWW price & chart
Loading TradingView…
OTC:QTIWW on TradingView ↗About the company
QT Imaging Holdings, Inc. (Nasdaq: QTI) is a medical device company engaged in the research, development, and commercialization of innovative imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on
In the news
No coverage from other publishers is available.
Recent filings
S-8 filing
4 filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Regulation FD Disclosure
Items 7.01, 9.01
10-Q filing
Show 5 more recent filings
Results of Operations and Financial Condition · Other Events
Items 2.02, 8.01, 9.01
4 filing
3 filing
S-8 filing
Submission of Matters to a Vote of Security Holders · Other Events
Items 5.07, 8.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 12,120,941Source | 6,960,443Source | 30,630,000Source | 11,631,817Source | 10,780,020Source | 22,028,000Source | 10,864,678Source | 12,857,812Source | 23,021,000Source | 6,086,673Source | 23,398,562Source | 41,945,571Source |
| Property, Plant and Equipment, NetUSD | 127,127Source | 122,152Source | 793,000Source | 166,676Source | 141,659Source | 315,000Source | 163,759Source | 154,073Source | 318,000Source | 195,783Source | — | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | — | 10,924,000Source | 2,022,000Source | — | 6,900,000Source | — | — | 10,412,000Source | — | — | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 3,243,706Source | 256,886Source | 7,404,000Source | 3,651,310Source | 669,138Source | 6,353,000Source | 2,782,404Source | 482,357Source | 5,781,000Source | 67,119Source | — | — |
| Inventory, NetUSD | 5,242,228Source | 3,181,554Source | 9,870,000Source | 3,231,098Source | 3,354,677Source | 6,826,000Source | 2,872,401Source | 4,116,228Source | 5,027,000Source | 3,140,719Source | — | — |
| Assets, CurrentUSD | 11,288,135Source | 5,778,194Source | 29,419,000Source | 10,667,892Source | 9,494,427Source | 21,197,000Source | 9,814,126Source | 11,434,105Source | 22,091,000Source | 4,916,494Source | 96,446Source | 250,704Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,066,801Source | 775,585Source | 1,171,000Source | 1,743,304Source | 869,472Source | 1,068,000Source | 1,151,818Source | 1,195,289Source | 821,000Source | 516,552Source | 94,008Source | 172,508Source |
| Operating Lease, Right-of-Use AssetUSD | 666,529Source | 1,020,947Source | 379,000Source | 758,099Source | 1,104,784Source | 477,000Source | 847,643Source | 1,186,815Source | 573,000Source | 935,246Source | — | — |
| Other Assets, NoncurrentUSD | 39,150Source | 39,150Source | 39,000Source | 39,150Source | 39,150Source | 39,000Source | 39,150Source | 39,150Source | 39,000Source | 39,150Source | — | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 21,197,385Source | 16,612,103Source | 28,384,000Source | 11,956,111Source | 16,939,389Source | 18,229,000Source | 31,072,036Source | 17,771,962Source | 16,576,000Source | 15,624,957Source | 12,690,494Source | 13,418,199Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — |
| Common Stock, Value, IssuedUSD | 967Source | 2,144Source | 1,000Source | 2,864Source | 2,144Source | 1,000Source | 2,765Source | 2,144Source | 1,000Source | 2,676Source | 655Source | 655Source |
| Additional Paid in CapitalUSD | 42,558,037Source | 18,800,230Source | 69,745,000Source | 46,750,884Source | 18,671,598Source | 60,228,000Source | 22,866,404Source | 13,482,441Source | 59,468,000Source | 22,399,567Source | — | — |
| Retained Earnings (Accumulated Deficit)USD | -51,635,448Source | -28,452,605Source | -67,500,000Source | -47,078,042Source | -24,833,111Source | -56,430,000Source | -43,076,527Source | -18,398,735Source | -53,024,000Source | -31,940,527Source | -17,104,720Source | -13,080,129Source |
| Stockholders' Equity Attributable to ParentUSD | -9,076,444Source | -9,651,660Source | 2,246,000Source | -324,000Source | -6,159,369Source | 3,799,000Source | -20,207,000Source | -4,914,150Source | 6,445,000Source | -9,538,284Source | -12,514,886Source | -13,079,474Source |
| Additional Paid in Capital, Common StockUSD | — | — | — | — | — | — | — | — | — | — | 4,589,179Source | — |
| Liabilities and EquityUSD | 12,120,941Source | 6,960,443Source | 30,630,000Source | 11,631,817Source | 10,780,020Source | 22,028,000Source | 10,864,678Source | 12,857,812Source | 23,021,000Source | 6,086,673Source | 23,398,562Source | 41,945,571Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 12,742,881Source | 5,433,851Source | 9,499,000Source | 6,306,539Source | 15,267,342Source | 8,525,000Source | 5,282,701Source | 4,371,394Source | 7,868,000Source | 9,794,116Source | 12,682,544Source | 4,186,399Source |
| Operating Lease, Liability, CurrentUSD | 441,634Source | 394,208Source | 437,000Source | 429,350Source | 382,964Source | 467,000Source | 417,379Source | 372,010Source | 454,000Source | 405,678Source | — | — |
| Accounts Payable, CurrentUSD | 2,019,136Source | 768,264Source | 3,011,000Source | 1,595,789Source | 549,583Source | 2,927,000Source | 869,579Source | 711,773Source | 3,580,000Source | 803,286Source | 767,615Source | 195,064Source |
| Operating Lease, Liability, NoncurrentUSD | 321,270Source | 762,904Source | 0Source | 437,411Source | 866,761Source | 82,000Source | 548,874Source | 966,253Source | 203,000Source | 656,955Source | — | — |
| Other Liabilities, NoncurrentUSD | 1,349,409Source | 507,029Source | 996,000Source | 986,044Source | 0Source | 1,931,000Source | 685,470Source | 465,081Source | 1,614,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 5,235,216Source | 3,364,217Source | 6,051,000Source | 4,210,416Source | 4,192,015Source | 5,131,000Source | 3,887,920Source | 2,813,262Source | 3,825,000Source | 3,549,954Source | 893,830Source | 103,344Source |
| Long-term DebtUSD | 15,122,966Source | 10,483,292Source | 11,397,000Source | 10,136,698Source | 11,661,330Source | 10,100,000Source | 10,163,180Source | 11,693,878Source | 10,109,000Source | 9,933,392Source | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | -4,024,591Source | -2,774,307Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | 21,000Source | 38,000Source | 20,000Source | 38,000Source | 131,000Source | 230,804Source | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 381,000Source | 101,000Source | 801,000Source | 289,795Source | — | — |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 572,000Source | 2,715,000Source | 5,714,000Source | 67,119Source | — | — |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 1,799,000Source | -268,000Source | 1,925,000Source | -1,506,746Source | — | — |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -495,000Source | 61,000Source | 2,452,000Source | -1,954,768Source | 572,551Source | 166,964Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -3,654,000Source | -3,536,000Source | -8,959,000Source | -10,033,477Source | -1,944,104Source | -1,261,550Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -17,000Source | 0Source | -124,000Source | -87,790Source | 19,919,611Source | 192,241,509Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 17,000Source | 0Source | 124,000Source | 87,790Source | — | — |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 159,000Source | 5,352,000Source | 18,353,000Source | 11,128,685Source | -18,051,265Source | -191,323,312Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | 9,000Source | 4,648,000Source | 9,702,000Source | 1,275,773Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -3,512,000Source | 1,816,000Source | 9,270,000Source | 1,007,418Source | -75,758Source | -343,353Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 1,735,400Source | 1,564,169Source | 10,974,000Source | 2,042,000Source | — | 3,007,503Source | 10,462,000Source | — | — | — |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 0Source | 12,000Source | 431,000Source | 539,266Source | — | — |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | — | — | 427,977Source | 400,377Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 198,795Source | 127,203Source | 668,000Source | 219,000Source | 381,000Source | 101,000Source | 801,000Source | 289,795Source | — | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | — | — | — | — | 219,686Source | 17,914Source |
| Amortization of Intangible AssetsUSD | — | — | — | 0Source | — | — | — | — | — | 90,139Source | — | — |
| DepreciationUSD | — | — | 39,550Source | 19,508Source | — | 38,293Source | — | 37,631Source | 100,000Source | 140,665Source | — | — |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | 0Source | 87,200Source | 0Source | 0Source | 0Source | 101,000Source | 101,000Source | 4,817,600Source | — | — |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | — | — | — | — | — | — | 0Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | -8,294,000Source | 0Source | 0Source | -2,034,000Source | -2,080,000Source | -383,511Source | — | — |
| General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 4,927,599Source | 4,279,100Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 2,000Source | 3,000Source | — | — | -1,000Source | -15,783Source | 419,119Source | 486,615Source |
| Induced Conversion of Convertible Debt ExpenseUSD | — | — | — | — | 0Source | 0Source | 0Source | 6,640,000Source | 6,640,000Source | 0Source | — | — |
| Investment Income, InterestUSD | — | — | — | — | — | — | — | — | — | — | 1,526,860Source | 1,630,398Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -4,557,406Source | -3,619,494Source | -11,070,000Source | -4,002,000Source | -3,406,000Source | -11,136,000Source | -21,083,000Source | -8,984,880Source | -4,024,591Source | -2,774,307Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -4,557,406Source | -3,619,494Source | -11,070,000Source | -4,002,000Source | -3,406,000Source | -11,136,000Source | -21,083,000Source | -14,170,382Source | -5,132,332Source | -3,918,090Source |
| Noncash Merger Related CostsUSD | — | — | — | — | — | — | — | 0Source | 0Source | 3,698,350Source | — | — |
| Operating ExpensesUSD | — | — | 3,454,752Source | 2,932,491Source | 4,924,000Source | 2,870,000Source | 5,021,000Source | 2,854,000Source | 13,021,000Source | 14,816,852Source | — | — |
| Operating Lease, ExpenseUSD | — | — | 113,971Source | 113,748Source | 100,000Source | 100,000Source | 100,000Source | 100,000Source | 500,000Source | 454,780Source | — | — |
| Other Nonoperating Income (Expense)USD | — | — | -30,559Source | 16,995Source | -4,000Source | 9,000Source | -1,057,000Source | -10,094,000Source | -16,647,000Source | -560,648Source | 14,953Source | 384,108Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 155,000Source | 0Source | 17,569,000Source | 999,998Source | — | — |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | 0Source | 10,000,000Source | 14,856,000Source | 10,525,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 245,000Source | 0Source | 75,000Source | — | — | — |
| Nonoperating Income (Expense) | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 4,192,101Source | 955,970Source | 7,435,000Source | 3,659,000Source | 6,530,000Source | 2,798,000Source | 18,925,000Source | 4,878,665Source | 0Source | — |
| Cost of RevenueUSD | — | — | 2,389,428Source | 350,667Source | 4,375,000Source | 1,832,000Source | 3,858,000Source | 986,000Source | 10,341,000Source | 2,238,820Source | — | — |
| Selling, General and Administrative ExpenseUSD | — | — | 2,515,994Source | 2,007,277Source | 3,300,000Source | 1,969,000Source | 3,297,000Source | 2,002,000Source | 9,085,000Source | 11,549,512Source | — | — |
| Operating Income (Loss)USD | — | — | -1,652,079Source | -2,327,188Source | -1,864,000Source | -1,043,000Source | -2,349,000Source | -1,042,000Source | -4,437,000Source | -12,177,007Source | -4,927,599Source | -4,279,100Source |
| Other Nonoperating Income (Expense)USD | — | — | -30,559Source | 16,995Source | -4,000Source | 9,000Source | -1,057,000Source | -10,094,000Source | -16,647,000Source | -560,648Source | 14,953Source | 384,108Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -4,557,406Source | -3,619,494Source | -11,068,000Source | -3,999,000Source | — | — | -21,084,000Source | -9,000,663Source | -3,605,472Source | -2,287,692Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 2,000Source | 3,000Source | — | — | -1,000Source | -15,783Source | 419,119Source | 486,615Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -4,557,406Source | -3,619,494Source | -11,070,000Source | -4,002,000Source | -3,406,000Source | -11,136,000Source | -21,083,000Source | -8,984,880Source | -4,024,591Source | -2,774,307Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.47Source | -0.51Source | -0.75Source | -0.42Source | -0.25Source | -1.21Source | -2.01Source | -0.71Source | -0.78Source | -0.6Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.47Source | -0.51Source | -0.75Source | -0.42Source | -0.25Source | -1.21Source | -2.01Source | -0.71Source | -0.78Source | -0.6Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 9,601,972Source | 7,155,505Source | 14,831,000Source | 9,451,000Source | 13,798,000Source | 9,172,000Source | 10,476,000Source | 19,977,330Source | 6,540,000Source | 6,540,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 9,601,972Source | 7,155,505Source | 14,831,000Source | 9,451,000Source | 13,798,000Source | 9,172,000Source | 10,476,000Source | 19,977,330Source | 6,540,000Source | 6,540,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | 0Source | — | — | — | — | — | 90,139Source | — | — |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -1,000Source | -15,783Source | 419,119Source | 486,615Source |
| General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 4,927,599Source | 4,279,100Source |
| Gross ProfitUSD | — | — | 1,802,673Source | 605,303Source | 3,060,000Source | 1,827,000Source | 2,672,000Source | 1,812,000Source | 8,584,000Source | 2,639,845Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -21,084,000Source | -9,000,663Source | -3,605,472Source | -2,287,692Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 219,686Source | 23,098Source |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | -564,725Source | -1,455,306Source | -745,000Source | -379,000Source | -930,000Source | -691,000Source | -2,639,000Source | -4,497,781Source | — | — |
| Investment Income, InterestUSD | — | — | — | — | — | — | — | — | — | — | 1,526,860Source | 1,630,398Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -4,557,406Source | -3,619,494Source | -11,070,000Source | -4,002,000Source | -3,406,000Source | -11,136,000Source | -21,083,000Source | -14,170,382Source | -5,132,332Source | -3,918,090Source |
| Operating ExpensesUSD | — | — | 3,454,752Source | 2,932,491Source | 4,924,000Source | 2,870,000Source | 5,021,000Source | 2,854,000Source | 13,021,000Source | 14,816,852Source | — | — |
| Operating Lease, ExpenseUSD | — | — | 113,971Source | 113,748Source | 100,000Source | 100,000Source | 100,000Source | 100,000Source | 500,000Source | 454,780Source | — | — |
| Preferred Stock Dividends and Other AdjustmentsUSD | — | — | 0Source | 0Source | — | 0Source | — | — | 0Source | 5,185,502Source | — | — |
| Research and Development ExpenseUSD | — | — | 938,758Source | 925,214Source | 1,624,000Source | 901,000Source | 1,724,000Source | 852,000Source | 3,936,000Source | 3,267,340Source | — | — |
| Nonoperating Income (Expense) | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
Filing attachments
ex41-formofprexfundedwarra.htm · 8-K · 2026-05-21
EXHIBIT 4.1 PRE-FUNDED COMMON STOCK PURCHASE WARRANT QT IMAGING HOLDINGS, INC. Warrant Shares: 800,000 Initial Exercise Date: May 18, 2026 CUSIP: 746962 125 ISIN: US7469621251 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, CEDE & CO., or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth abov…
Read attachment ↗ex42-globalwarrantcertific.htm · 8-K · 2026-05-21
EXHIBIT 4.2 FORM OF GLOBAL WARRANT CERTIFICATE OF WARRANT TO COMMON STOCK UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS RE…
Read attachment ↗ex991-investorpresentati.htm · 8-K · 2026-05-21
Quantitative Transmission Imaging Breast Acoustic CT Scanner May 2026 NASDAQ:QTI Copyright ©2026 QT Imaging, Inc. All Rights Reserved. 2 Disclaimer ABOUT THIS PRESENTATION This investor presentation (this “Presentation”) is provided for informational purposes only. The information contained herein does not purport to be all-inclusive and neither QT Imaging Holdings, Inc. (the “Company”, “QT Imaging Holdings”, “QTI”), nor its respective directors, officers, employees, agents, advisors or affilia…
Read attachment ↗ex992-pricingpressrelease.htm · 8-K · 2026-05-21
EXHIBIT 99.2 QT Imaging Holdings Announces Pricing of $10 Million Underwritten Public Offering NOVATO, Calif. - May 15, 2026 - QT Imaging Holdings, Inc. (“QT Imaging” or the “Company”) (Nasdaq: QTI), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, announced today the pricing of an underwritten public offering of 2,000,000 shares of common stock (or pre-funded warrants in lieu thereof) for gross proceeds of $10 m…
Read attachment ↗